Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rapid Micro Biosystems (RPID) Capital Expenditures (2020 - 2025)

Rapid Micro Biosystems' Capital Expenditures history spans 6 years, with the latest figure at $92000.0 for Q4 2025.

  • On a quarterly basis, Capital Expenditures fell 67.26% to $92000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $850000.0, a 175.08% increase, with the full-year FY2025 number at $850000.0, up 175.08% from a year prior.
  • Capital Expenditures hit $92000.0 in Q4 2025 for Rapid Micro Biosystems, down from $683000.0 in the prior quarter.
  • Over the last five years, Capital Expenditures for RPID hit a ceiling of $6.7 million in Q4 2022 and a floor of -$4.3 million in Q3 2022.
  • Historically, Capital Expenditures has averaged $648050.0 across 5 years, with a median of $456000.0 in 2021.
  • The widest YoY moves for Capital Expenditures: up 837.45% in 2022, down 1043.57% in 2022.
  • Tracing RPID's Capital Expenditures over 5 years: stood at $2.0 million in 2021, then skyrocketed by 242.27% to $6.7 million in 2022, then tumbled by 93.79% to $418000.0 in 2023, then crashed by 32.78% to $281000.0 in 2024, then plummeted by 67.26% to $92000.0 in 2025.
  • Business Quant data shows Capital Expenditures for RPID at $92000.0 in Q4 2025, $683000.0 in Q3 2025, and -$244000.0 in Q2 2025.